USA Financial Formulas’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.8K Sell
457
-4,747
-91% -$471K 0.01% 274
2026
Q1
$490K Buy
5,204
+3
+0.1% +$299 0.09% 79
2025
Q4
$514K Buy
+5,201
New +$503K 0.09% 81
2025
Q2
Sell
-11,937
Closed -$723K 303
2025
Q1
$723K Buy
+11,937
New +$832K 0.12% 72
2023
Q4
Sell
-9,945
Closed -$575K 440
2023
Q3
$575K Hold
9,945
0.86% 33
2023
Q2
$619K Sell
9,945
-2,062
-17% -$138K 0.95% 40
2023
Q1
$868K Buy
+12,007
New +$939K 1.41% 28
2022
Q3
$1.24M Buy
+18,571
New +$1.37M 1.95% 14

Other funds holding INCY

USA Financial Formulas's INCY Position: Q2 2026 in Review

USA Financial Formulas reduced its Incyte (INCY) stake by 91% in Q2 2026, selling an estimated $471K and leaving 457 shares worth $51.8K. The position accounts for 0.01% of the portfolio, ranked #274.

USA Financial Formulas first reported a position in INCY in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.24M in Q3 2022. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • USA Financial Formulas held 457 shares of Incyte worth $51.8K as of Q2 2026.
  • USA Financial Formulas sold 4,747 Incyte shares in Q2 2026, an estimated $471K.
  • Incyte made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #274 holding.
  • USA Financial Formulas first reported a position in Incyte in Q3 2022 and has held it in 8 quarters since.
  • USA Financial Formulas's Incyte position peaked at $1.24M in Q3 2022.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.